Caprihans India Limited Submits SEBI Compliance Certificate for Quarter Ended March 2026

1 min read     Updated on 03 Apr 2026, 03:55 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Caprihans India Limited filed its mandatory SEBI compliance certificate for the quarter ended March 31, 2026, on April 3, 2026. The certificate, submitted by Company Secretary Rajesh P. Likhite to BSE Limited, confirms adherence to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. MUFG Intime India Private Limited, the company's registrar, validated proper handling of dematerialization processes and compliance with prescribed timelines during the quarter.

powered bylight_fuzz_icon
36757511

*this image is generated using AI for illustrative purposes only.

Caprihans India Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission relates to the quarter ended March 31, 2026, and demonstrates the company's adherence to mandatory compliance protocols.

Regulatory Submission Details

The compliance certificate was filed on April 3, 2026, by Rajesh P. Likhite, Company Secretary and Compliance Officer of Caprihans India Limited. The submission was directed to BSE Limited at Phiroze Jeejeebhoy Towers, Mumbai, under the company's code number 509486.

Parameter: Details
Filing Date: April 3, 2026
Quarter Ended: March 31, 2026
Regulation: SEBI Regulation 74(5)
BSE Code: 509486
Filed By: Rajesh P. Likhite, Company Secretary

Registrar Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the Registrar and Share Transfer Agent for Caprihans India Limited. The registrar issued its confirmation certificate on April 1, 2026, validating compliance with dematerialization requirements.

The registrar confirmed that securities received from depository participants for dematerialization during the quarter ended March 31, 2026, were properly processed and confirmed to the depositories. Additionally, MUFG Intime India confirmed that all security certificates received for dematerialization were appropriately handled within prescribed timelines.

Compliance Verification

The certificate validates several key compliance aspects:

  • Securities received for dematerialization were confirmed or rejected to depositories as required
  • Listed securities maintain compliance with stock exchange requirements
  • Security certificates were properly mutilated and cancelled after verification
  • Depository names were substituted in the register of members within prescribed timelines

Ashok Shetty, Senior Vice President-Corporate Registry at MUFG Intime India Private Limited, signed the confirmation certificate, ensuring proper authorization and validation of the compliance processes.

Corporate Information

Caprihans India Limited operates from its registered office at Plot C-13/16, Road No-16T, Wagle Industrial Estate, Thane, Mumbai. The company maintains its corporate communications through its Pune office at ICC Trade Towers, demonstrating its operational presence across key business centers in Maharashtra.

Historical Stock Returns for Caprihans

1 Day5 Days1 Month6 Months1 Year5 Years
+6.55%+12.73%-14.23%-47.86%-52.61%-21.52%

Will Caprihans India Limited's consistent regulatory compliance improve its ESG ratings and attract institutional investors in 2026?

How might the rebranding of Link Intime to MUFG Intime India impact registrar services and costs for listed companies like Caprihans?

Could Caprihans India's operational expansion across Maharashtra signal plans for broader geographic diversification or new business ventures?

Bilcare Limited files SEBI disclosure for warrant conversion in Caprihans India

2 min read     Updated on 27 Mar 2026, 03:56 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Bilcare Limited submitted official SEBI (SAST) regulatory disclosure for the fourth tranche warrant conversion in Caprihans India Limited, converting 3.30 lakh warrants into equity shares on March 25, 2026. The comprehensive filing details the systematic conversion pattern across four tranches, increasing Bilcare's shareholding from 58.70% to 59.56%, with equity capital rising to ₹15.91 crores and 20.20 lakh warrants remaining for potential future conversion.

powered bylight_fuzz_icon
35562355

*this image is generated using AI for illustrative purposes only.

Caprihans India Limited received official SEBI (SAST) regulatory disclosure from promoter Bilcare Limited regarding the fourth tranche warrant conversion completed on March 25, 2026. The comprehensive filing under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 confirms the conversion of 3.30 lakh warrants into equity shares, increasing Bilcare Limited's shareholding to 59.56%.

Official SEBI SAST Regulatory Disclosure

Bilcare Limited submitted detailed disclosure documentation to BSE Limited and Caprihans India Limited, confirming the exercise of warrant conversion rights during the fourth tranche of the financial year 2025-26. Company Secretary Sagar R. Baheti executed the mandatory filing with comprehensive details of the preferential allotment pursuant to convertible warrant conversion.

Conversion Details: Fourth Tranche
Conversion Date: March 25, 2026
Warrants Converted: 3,30,000
Equity Shares Allotted: 3,30,000
Initial Warrant Holding: 23,50,000
Remaining Warrants: 20,20,000
BSE Scrip Code: 509486

Progressive Shareholding Pattern Analysis

The regulatory disclosure provides comprehensive details of all four warrant conversion tranches executed during financial year 2025-26. Bilcare Limited's systematic conversion pattern demonstrates consistent exercise of warrant rights, with shareholding progression from 55.99% to 59.56% across the conversion period.

Conversion Timeline: Date Shares Converted Shareholding Before Shareholding After
First Tranche: March 20, 2026 3,00,000 55.99% 56.88%
Second Tranche: March 23, 2026 3,30,000 56.88% 57.81%
Third Tranche: March 24, 2026 3,30,000 57.81% 58.70%
Fourth Tranche: March 25, 2026 3,30,000 58.70% 59.56%

Current Shareholding Structure

Following the latest warrant conversion, Bilcare Limited's equity shareholding increased from 91.48 lakh shares to 94.78 lakh shares, representing 59.56% of the total paid-up equity share capital. The disclosure confirms the company's position as sole promoter with significant remaining warrant holdings for potential future conversions.

Shareholding Analysis: Before Conversion After Conversion
Equity Shares Held: 91,48,325 94,78,325
Shareholding Percentage: 58.70% 59.56%
Shares Acquired: - 3,30,000
Percentage Increase: - 0.86%
Public Shareholding: 41.30% 40.44%

Capital Structure Impact Assessment

The regulatory filing details the equity share capital increase from ₹15.58 crores to ₹15.91 crores following the warrant conversion. The disclosure includes comprehensive diluted share capital calculations assuming full conversion of the remaining 20.20 lakh warrants, projecting total diluted capital of ₹17.93 crores.

Capital Structure: Amount
Equity Capital Before: ₹15,58,39,710
Equity Capital After: ₹15,91,39,710
Capital Increase: ₹33,00,000
Total Diluted Capital: ₹17,93,39,710
Remaining Warrants: 20,20,000

Regulatory Compliance Framework

The comprehensive disclosure demonstrates full compliance with SEBI (SAST) Regulations, 2011, including detailed acquisition particulars, mode of acquisition through preferential allotment, and post-conversion shareholding patterns. The filing confirms the transaction execution in accordance with applicable provisions of the Companies Act, 2013 and SEBI regulations.

Regulatory Framework: Details
Filing Regulation: SEBI (SAST) Regulations, 2011
Disclosure Type: Regulation 29(2)
Acquisition Mode: Preferential Allotment
Filing Officer: Sagar R. Baheti
Filing Date: March 25, 2026
BSE Scrip ID: CAPRIHANS

Historical Stock Returns for Caprihans

1 Day5 Days1 Month6 Months1 Year5 Years
+6.55%+12.73%-14.23%-47.86%-52.61%-21.52%

Will Bilcare Limited convert the remaining 20.20 lakh warrants to further increase its shareholding beyond 60%, and what timeline might they follow?

How might the reduction in public shareholding to 40.44% impact Caprihans India's liquidity and compliance with minimum public shareholding requirements?

What strategic initiatives or expansion plans might Bilcare Limited pursue with the increased capital infusion of ₹33 crores from this warrant conversion?

More News on Caprihans

1 Year Returns:-52.61%